Regulating tumor suppressor genes: post-translational modifications
L Chen, S Liu, Y Tao - Signal transduction and targeted therapy, 2020 - nature.com
Tumor suppressor genes cooperate with each other in tumors. Three important tumor
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …
Targeting transcription factors for cancer treatment
M Lambert, S Jambon, S Depauw… - Molecules, 2018 - mdpi.com
Transcription factors are involved in a large number of human diseases such as cancers for
which they account for about 20% of all oncogenes identified so far. For long time, with the …
which they account for about 20% of all oncogenes identified so far. For long time, with the …
An overview of spirooxindole as a promising scaffold for novel drug discovery
LM Zhou, RY Qu, GF Yang - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Introduction: Spirooxindole, a unique and versatile scaffold, has been widely studied in
some fields such as pharmaceutical chemistry and synthetic chemistry. Especially in the …
some fields such as pharmaceutical chemistry and synthetic chemistry. Especially in the …
Interfering peptides targeting protein–protein interactions: the next generation of drugs?
H Bruzzoni-Giovanelli, V Alezra, N Wolff, CZ Dong… - Drug Discovery …, 2018 - Elsevier
Highlights•Structure-based strategies allow more-specific targeting of protein–protein
interactions (PPIs).•Interfering peptides (IPs) become a promising alternative to small …
interactions (PPIs).•Interfering peptides (IPs) become a promising alternative to small …
[HTML][HTML] Natural products targeting the p53-MDM2 pathway and mutant p53: recent advances and implications in cancer medicine
The p53 tumor suppressor plays a major role in controlling the initiation and development of
cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 …
cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 …
[HTML][HTML] Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions
M Munisamy, N Mukherjee, L Thomas… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Ubiquitination is a key enzymatic post-translational modification that influences p53 stability
and function. p53 protein regulates the expression of MDM2 (mouse double-minute 2 …
and function. p53 protein regulates the expression of MDM2 (mouse double-minute 2 …
Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA Analysis …
Potentilla nepalensis belongs to the Rosaceae family and has numerous therapeutic
applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and …
applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and …
Transcriptional repression of aerobic glycolysis by OVOL2 in breast cancer
X Zhang, F Luo, S Luo, L Li, X Ren, J Lin… - Advanced …, 2022 - Wiley Online Library
Aerobic glycolysis (Warburg effect), a hallmark of cancer, plays a critical role in cancer cell
growth and metastasis; however, direct inhibition of the Warburg effect remains largely …
growth and metastasis; however, direct inhibition of the Warburg effect remains largely …
Recent small-molecule inhibitors of the p53–MDM2 protein–protein interaction
A Beloglazkina, N Zyk, A Majouga, E Beloglazkina - Molecules, 2020 - mdpi.com
This review presents the last decade of studies on the synthesis of various types of small-
molecule inhibitors of the p53–Mouse double minute 2 homolog (MDM2) protein–protein …
molecule inhibitors of the p53–Mouse double minute 2 homolog (MDM2) protein–protein …
From the evasion of degradation to ubiquitin-dependent protein stabilization
Y Abu Ahmad, A Oknin-Vaisman, E Bitman-Lotan… - Cells, 2021 - mdpi.com
A hallmark of cancer is dysregulated protein turnover (proteostasis), which involves
pathologic ubiquitin-dependent degradation of tumor suppressor proteins, as well as …
pathologic ubiquitin-dependent degradation of tumor suppressor proteins, as well as …